Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Lantheus Holdings, Inc.

10% Owner at Perspective Therapeutics, Inc. (CATX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $488K

Reported trades

Filed Stock Type Shares Price Value Since
Sep 4SEC CATXPerspective Therapeutics, Inc. Sell 42,12911,521,296 held (−0%) $3.11 $131K -30.2%
Sep 3SEC CATXPerspective Therapeutics, Inc. Sell 35,76911,563,425 held (−0%) $3.12 $112K -30.4%
Sep 2SEC CATXPerspective Therapeutics, Inc. Sell 78,14511,599,194 held (−1%) $3.14 $245K -30.9%